Global X Japan Co. Ltd. Increases Stock Holdings in Intuitive Surgical, Inc. $ISRG

Global X Japan Co. Ltd. grew its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 27.4% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 51,005 shares of the medical equipment provider’s stock after purchasing an additional 10,980 shares during the period. Intuitive Surgical makes up approximately 2.2% of Global X Japan Co. Ltd.’s portfolio, making the stock its 13th biggest holding. Global X Japan Co. Ltd.’s holdings in Intuitive Surgical were worth $28,887,000 at the end of the most recent reporting period.

Several other hedge funds have also recently modified their holdings of the stock. Holos Integrated Wealth LLC acquired a new position in Intuitive Surgical in the 4th quarter valued at $25,000. Kilter Group LLC acquired a new stake in shares of Intuitive Surgical in the 2nd quarter worth $27,000. Olistico Wealth LLC purchased a new stake in shares of Intuitive Surgical in the fourth quarter valued at about $28,000. Greykasell Wealth Strategies Inc. purchased a new stake in shares of Intuitive Surgical in the third quarter valued at about $27,000. Finally, Caitlin John LLC acquired a new position in shares of Intuitive Surgical during the third quarter worth about $30,000. 83.64% of the stock is owned by institutional investors and hedge funds.

Intuitive Surgical Trading Down 0.3%

ISRG stock opened at $468.55 on Friday. The firm has a 50 day moving average of $496.15 and a 200-day moving average of $513.04. Intuitive Surgical, Inc. has a 12-month low of $425.00 and a 12-month high of $603.88. The company has a market cap of $166.40 billion, a price-to-earnings ratio of 59.39, a PEG ratio of 3.63 and a beta of 1.66.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 earnings per share for the quarter, topping analysts’ consensus estimates of $2.27 by $0.26. Intuitive Surgical had a return on equity of 15.06% and a net margin of 28.38%.The business had revenue of $2.87 billion for the quarter, compared to analysts’ expectations of $2.72 billion. During the same quarter in the prior year, the firm posted $2.21 EPS. The company’s revenue was up 18.8% compared to the same quarter last year. Sell-side analysts forecast that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Analysts Set New Price Targets

ISRG has been the subject of several analyst reports. Wells Fargo & Company increased their price target on shares of Intuitive Surgical from $600.00 to $654.00 and gave the stock an “overweight” rating in a report on Friday, December 12th. Barclays set a $712.00 target price on Intuitive Surgical and gave the stock an “overweight” rating in a research report on Monday, January 26th. HSBC increased their target price on Intuitive Surgical from $644.00 to $653.00 and gave the stock a “buy” rating in a research note on Monday, January 26th. Robert W. Baird decreased their price target on Intuitive Surgical from $655.00 to $645.00 and set an “outperform” rating on the stock in a research note on Friday, January 23rd. Finally, Citigroup raised Intuitive Surgical from a “neutral” rating to a “buy” rating and set a $590.00 price objective on the stock in a report on Wednesday, March 11th. Two equities research analysts have rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating, six have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $614.95.

Intuitive Surgical News Summary

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Intuitive is taking direct control of da Vinci and Ion distribution in Southern Europe to improve sales, service and system availability — a move that should support long‑term revenue and customer uptime in a strategic region. Intuitive Surgical Extends Southern Europe Reach As Stock Trades Below Targets
• Positive Sentiment: Wall Street and retail commentary remain constructive: several recent pieces label ISRG a top pure‑play robotics buy and say analyst recommendations are generally favorable, supporting investor conviction around market leadership and long runway. Is Intuitive Surgical Inc. (ISRG) the best pure-play robotics stock to buy now?
• Positive Sentiment: Former management highlights Intuitive’s competitive moat in clinician training and ecosystem lock‑in — an important qualitative advantage that supports recurring procedure volume and replacement/system upgrade demand. Intuitive Surgical stock moat lies in training, former exec says
• Neutral Sentiment: Underlying fundamentals remain solid: the company posted a revenue and EPS beat in the most recent quarter (strong procedure growth and high margins), but those results are already priced into a premium multiple, so impact on near‑term price is mixed.
• Negative Sentiment: Shares have been under pressure — trading below some analyst targets and showing YTD weakness — which can amplify downside on headline volatility or broader market risk‑off days. Intuitive Surgical, Inc. (ISRG) Suffers a Larger Drop Than the General Market: Key Insights
• Negative Sentiment: High valuation (elevated P/E) means the stock is sensitive to execution misses, slower procedure adoption or tougher macro conditions — risks investors are currently re‑pricing into the stock.

Insider Transactions at Intuitive Surgical

In other Intuitive Surgical news, SVP Patricia L. Wadors sold 220 shares of the company’s stock in a transaction on Friday, February 27th. The stock was sold at an average price of $499.71, for a total value of $109,936.20. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, SVP Mark Brosius sold 645 shares of the firm’s stock in a transaction on Monday, March 9th. The shares were sold at an average price of $485.01, for a total value of $312,831.45. Following the completion of the transaction, the senior vice president owned 1,613 shares of the company’s stock, valued at approximately $782,321.13. This represents a 28.57% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold a total of 32,943 shares of company stock valued at $17,279,568 in the last three months. 0.60% of the stock is owned by company insiders.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.